semaglutide for alzheimer's GLP-1 Drug Fails to Quell in Novo Nordisk Trials Semaglutide May Cut Alzheimer's Risk
Description
Lets continue the discussion below
Belle Health uses a provider-guided titration approach
So much hell
The new study offered a clue as to why: Among those taking GLP-1 receptor agonists, those whose tumors had more GLP-1 receptors were less likely to have their cancer metastasize, the researchers said
With GLP-1 shortages, compounded versions have popped upbut are they safe
